Delivery Order SPE2DR25D2104-SPE2DR26F3SMN
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $13,867.55 to AmerisourceBergen Drug Corp for the supply of Rexulti 2 mg tablets (30-count units). This firm fixed-price delivery order, executed on December 4, 2025, with completion targeted for December 5, 2025, represents a competitively awarded contract with no set-aside designation. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $1,795.05 to AmerisourceBergen Drug Corp for the supply of Rexulti 1 mg tablets (30-count units) on December 29, 2025. This firm fixed price delivery order is set to be completed by December 30, 2025, and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a non-competitive, competitively-awarded transaction under an existing contract vehicle, reflecting...
- The Defense Logistics Agency awarded a delivery order valued at $13,026.20 to AmerisourceBergen Drug Corp on June 27, 2025, for the supply of Rexulti 3 mg tablets (30-count units). This firm fixed-price, non-competitive delivery order is scheduled for completion by June 30, 2025, with performance occurring at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement supporting federal medical supply needs. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $10,036.57 to AmerisourceBergen Drug Corp for the supply of Rexulti 2 mg tablets (30-count units) under a firm fixed-price contract type. The award was made on August 26, 2025, with an ultimate completion date of August 27, 2025, and represents a non-competitive, non-set-aside procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the delivery order from its Conshohocken facility. This...
- The Defense Logistics Agency awarded a delivery order valued at $8,064.96 to AmerisourceBergen Drug Corp for the supply of Rexulti 1 mg tablets (30-count packaging) on December 18, 2025, with an ultimate completion date of December 19, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a small-value transaction under AmerisourceBergen's larger pharmaceutical supply contract vehicle. The product will be delivered to the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, valued at $18,081.18, for 30-count tablets of Rexulti 1 mg on September 15, 2025, with completion scheduled for September 16, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a single transaction under the company's broader pharmaceutical supply relationship with the federal government. The product will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,890.22 to AmerisourceBergen Drug Corp for the supply of Rexulti 0.5 mg tablets (30-count units) on December 17, 2025, with an ultimate completion date of December 18, 2025. This firm fixed-price, non-competitive delivery order represents a continuation of AmerisourceBergen's extensive role as a pharmaceutical supplier to the federal government. The contract will be performed at the vendor's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $3,495.08 to AmerisourceBergen Drug Corp for the supply of Rexulti 2 mg tablets (30-count units) under a firm fixed price contract type. The order, issued on November 10, 2025, with an ultimate completion date of November 12, 2025, represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $17,977.69 to AmerisourceBergen Drug Corp for the supply of Rexulti 2 mg tablets (quantity: 30 count) under a firm fixed price contract. The award was made on August 20, 2025, with an ultimate completion date of August 21, 2025. This is a non-set-aside competitive award, with performance to be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $7,809.99 on September 16, 2025, for the supply of Rexulti 1 mg tablets (30-count package). This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by September 17, 2025. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the pharmaceutical distributor maintains its corporate headquarters. This delivery order...
- SPE2DR25D2104Indefinite Delivery Contract
- SPE2DR25D2104-SPE2DR26F3SMNDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $7,691.76 to AmerisourceBergen Drug Corp for the supply of Rexulti 1 mg tablets (30-count package). This competitively awarded, firm fixed-price delivery order was issued on December 30, 2025, with an ultimate completion date of December 31, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. This prime contract vehicle provides comprehensive global pharmaceutical support to military healthcare programs, enabling the delivery of a broad range of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. AmerisourceBergen's extensive federal contract portfolio demonstrates its critical role as a pharmaceutical distributor supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through flexible and competitive procurement arrangements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.7k | 12/29/25 |